These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 31980903)
1. O-GlcNAcylation of light chain serine 12 mediates rituximab production doubled by thiamet G. Kim HY; Park M; Kang C; Heo W; Yoon SM; Lee J; Kim JY Bioprocess Biosyst Eng; 2020 May; 43(5):863-875. PubMed ID: 31980903 [TBL] [Abstract][Full Text] [Related]
2. Osteoclast Differentiation Is Suppressed by Increased O-GlcNAcylation Due to Thiamet G Treatment. Takeuchi T; Horimoto Y; Oyama M; Nakatani S; Kobata K; Tamura M; Arata Y; Hatanaka T Biol Pharm Bull; 2020; 43(10):1501-1505. PubMed ID: 32999159 [TBL] [Abstract][Full Text] [Related]
3. Thiamet-G-mediated inhibition of O-GlcNAcase sensitizes human leukemia cells to microtubule-stabilizing agent paclitaxel. Ding N; Ping L; Shi Y; Feng L; Zheng X; Song Y; Zhu J Biochem Biophys Res Commun; 2014 Oct; 453(3):392-7. PubMed ID: 25268318 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of an O-GlcNAcase inhibitor on tau phosphorylation. Yu Y; Zhang L; Li X; Run X; Liang Z; Li Y; Liu Y; Lee MH; Grundke-Iqbal I; Iqbal K; Vocadlo DJ; Liu F; Gong CX PLoS One; 2012; 7(4):e35277. PubMed ID: 22536363 [TBL] [Abstract][Full Text] [Related]
6. Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors. Lim S; Haque MM; Nam G; Ryoo N; Rhim H; Kim YK Int J Mol Sci; 2015 Aug; 16(9):20212-24. PubMed ID: 26343633 [TBL] [Abstract][Full Text] [Related]
7. Thymidylate synthase O-GlcNAcylation: a molecular mechanism of 5-FU sensitization in colorectal cancer. Very N; Hardivillé S; Decourcelle A; Thévenet J; Djouina M; Page A; Vergoten G; Schulz C; Kerr-Conte J; Lefebvre T; Dehennaut V; El Yazidi-Belkoura I Oncogene; 2022 Jan; 41(5):745-756. PubMed ID: 34845374 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological Inhibition of O-GlcNAcase Does Not Increase Sensitivity of Glucocorticoid Receptor-Mediated Transrepression. Stivers PJ; Harmonay L; Hicks A; Mehmet H; Morris M; Robinson GM; Strack PR; Savage MJ; Zaller DM; Zwierzynski I; Brandish PE PLoS One; 2015; 10(12):e0145151. PubMed ID: 26670328 [TBL] [Abstract][Full Text] [Related]
9. Upregulated protein O-GlcNAcylation promoted functional and structural recovery of the contused spinal cord injury in rats by Thiamet-G treatment. Liang H; Xu L; Gao A; Shao Y; Yang S; Jiang Z; Ma W; Zhu S; Lin T; Zhang X Neurol Res; 2019 Sep; 41(9):780-790. PubMed ID: 31092134 [TBL] [Abstract][Full Text] [Related]
10. Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis. Decourcelle A; Loison I; Baldini S; Leprince D; Dehennaut V Biochem Biophys Res Commun; 2020 Jan; 521(1):125-130. PubMed ID: 31630803 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice. Hastings NB; Wang X; Song L; Butts BD; Grotz D; Hargreaves R; Fred Hess J; Hong KK; Huang CR; Hyde L; Laverty M; Lee J; Levitan D; Lu SX; Maguire M; Mahadomrongkul V; McEachern EJ; Ouyang X; Rosahl TW; Selnick H; Stanton M; Terracina G; Vocadlo DJ; Wang G; Duffy JL; Parker EM; Zhang L Mol Neurodegener; 2017 May; 12(1):39. PubMed ID: 28521765 [TBL] [Abstract][Full Text] [Related]
12. A correlation between altered O-GlcNAcylation, migration and with changes in E-cadherin levels in ovarian cancer cells. Jin FZ; Yu C; Zhao DZ; Wu MJ; Yang Z Exp Cell Res; 2013 Jun; 319(10):1482-90. PubMed ID: 23524144 [TBL] [Abstract][Full Text] [Related]
13. Effects of Global Sherazi AA; Jariwala KA; Cybulski AN; Lewis JW; Karagiannis J; Cumming RC; Timoshenko AV Anticancer Res; 2018 Dec; 38(12):6691-6697. PubMed ID: 30504378 [TBL] [Abstract][Full Text] [Related]
14. The increase in O-linked N-acetylglucosamine protein modification stimulates chondrogenic differentiation both in vitro and in vivo. Andrés-Bergós J; Tardio L; Larranaga-Vera A; Gómez R; Herrero-Beaumont G; Largo R J Biol Chem; 2012 Sep; 287(40):33615-28. PubMed ID: 22859309 [TBL] [Abstract][Full Text] [Related]
15. XBP1 (X-Box-Binding Protein-1)-Dependent O-GlcNAcylation Is Neuroprotective in Ischemic Stroke in Young Mice and Its Impairment in Aged Mice Is Rescued by Thiamet-G. Jiang M; Yu S; Yu Z; Sheng H; Li Y; Liu S; Warner DS; Paschen W; Yang W Stroke; 2017 Jun; 48(6):1646-1654. PubMed ID: 28487326 [TBL] [Abstract][Full Text] [Related]
17. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro. Zhang N; Chen X Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304 [TBL] [Abstract][Full Text] [Related]
18. Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells. Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V Oncol Rep; 2015 Oct; 34(4):1933-42. PubMed ID: 26252736 [TBL] [Abstract][Full Text] [Related]
19. Increasing O-GlcNAcylation Attenuates tau Hyperphosphorylation and Behavioral Impairment in rTg4510 Tauopathy Mice. Rostgaard N; Jul PH; Garmer M; Volbracht C J Integr Neurosci; 2023 Sep; 22(5):135. PubMed ID: 37735138 [TBL] [Abstract][Full Text] [Related]
20. O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-β protein precursor via inhibition of endocytosis from the plasma membrane. Chun YS; Park Y; Oh HG; Kim TW; Yang HO; Park MK; Chung S J Alzheimers Dis; 2015; 44(1):261-75. PubMed ID: 25208619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]